A team of researchers at University of Utah Health have shown the Epstein-Barr virus—which causes mononucleosis and is linked to development of several cancers—uses a novel strategy to survive. The virus takes the reins ...
May 29, 2020
0
429
Why don't we have drugs to treat COVID-19 and how long will it take to develop them?
Mar 20, 2020
0
419
There's more evidence that one of the world's most common viruses may set some people on the path to developing multiple sclerosis.
Jan 16, 2022
0
31
As SARS-CoV-2 has evolved and mutated, therapeutic antibodies that worked early in the pandemic have become less effective, and newer variants, especially omicron, have developed ways to evade the antibodies we make in response ...
Aug 11, 2022
0
170
A new paper in Biology Methods & Protocols indicates that researchers in Germany have developed a new system to display epitopes in mammal cells for immunization studies. They believe that this method can help scientists ...
Dec 12, 2023
0
21
To successfully infect its host, the rabies virus must move from the nerve ending to the nerve cell body where it can replicate.
Aug 23, 2018
0
328
Rabies virus is incurable and almost always fatal once it has invaded the central nervous system, with the victim doomed to suffer a horrible death.
Sep 28, 2023
0
35
More and more evidence is coming out that people with COVID-19 are suffering from cognitive effects, such as brain fog and fatigue.
Dec 17, 2020
2
1831
A research team spanning four continents has detailed the anti-viral capabilities of OSU-03012, also known as AR-12, a drug currently used in clinical trials to treat certain cancer tumors. The present study confirms that ...
Jul 5, 2016
0
96
A new UC San Francisco study has shown that a cancer-killing ("oncolytic") virus currently in clinical trials may function as a cancer vaccine—in addition to killing some cancer cells directly, the virus alerts the immune ...
Feb 13, 2018
1
1267
